Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cheryl Pater"'
Autor:
Pete Smith, Michael A. Lochrie, Peter Colosi, Kris Jones, Gwen Tatsuno, Alejandra E. Arbetman, Shang Zhen Zhou, Cheryl Pater, Michiko Kachi, Glenn F. Pierce, Jennifer Wellman McDonnell, Peter A. Campochiaro, Shu Kachi
Publikováno v:
Virology. 353:68-82
Using polymerase chain reactions and genome walking strategies, adeno-associated virus (AAV)-like capsid genes were isolated from rat and mouse liver genomic DNA, where they are present at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a4ba283d11c97687a5ef5138d385ee8
https://doi.org/10.1016/j.virol.2006.05.023
https://doi.org/10.1016/j.virol.2006.05.023
Autor:
Michael T. Lipari, Canio J. Refino, Stuart Bunting, Cheryl Pater, Brent Blackburn, Nishit B. Modi, Kirk Robarge, Thomas Weller, Sherron Bullens, Maureen Beresini, Beat Steiner
Publikováno v:
Scopus-Elsevier
SummaryRo 44-3888 is a potent and selective antagonist of GP IIb/IIIa. Following IV administration to rhesus monkeys, the (mean ± SD.) clear ance, volume of distribution and terminal half-life of Ro 44-3888 were 4.4 ± 1.8 ml/min/kg, 0.8 ± 0.4 l/kg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b3632af3c651af1b6d254e7d3fcf577
https://doi.org/10.1055/s-0037-1614238
https://doi.org/10.1055/s-0037-1614238
Autor:
Stuart Bunting, Pat Sehl, Robert F. Kelley, Cheryl Pater, Mark P. O'Connell, Canio J. Refino, Nishit B. Modi, David G. Lowe
Publikováno v:
Blood. 89:3219-3227
One approach to developing safer and more efficacious agents for the treatment of thrombotic disease involves the design and testing of inhibitors that block specific steps in the coagulation cascade. We describe here the development of a mutant of h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86ec6794745ee0dd7d343b8ade4ba48a
https://doi.org/10.1182/blood.v89.9.3219
https://doi.org/10.1182/blood.v89.9.3219
Autor:
Cheryl Pater, John Ogez, William F. Bennett, Florian M. Wurm, Bruce Keyt, J M Badillo, Nicholas F. Paoni, Canio J. Refino
Publikováno v:
Thrombosis and Haemostasis. 70:313-319
SummaryIn the accompanying paper, we reported that the properties of decreased plasma clearance rate, increased fibrin specificity, and resistance to inactivation by PAI-1 could be effectively combined in the t-PA variant T103N, KHRR 296-299 AAAA. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da7af9ef45e54dbdea782d29d1b07b5b
https://doi.org/10.1055/s-0038-1649572
https://doi.org/10.1055/s-0038-1649572
Publikováno v:
Lab Animal. 44:359-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0668212fc5aa209a047aa114e27ea0df
https://doi.org/10.1038/laban.836
https://doi.org/10.1038/laban.836
Autor:
Glenn F. Pierce, Shangzhen Zhou, Peter Colosi, Britta Randlev, Lea Ann Hobbs, Cheryl Pater, Jennifer Wellman, Howard D. Lehmkuhl, Richard T. Surosky, Michael A. Lochrie, Alejandra E. Arbetman
Publikováno v:
Molecular Therapy. 9:S35-S36
Top of pageAbstract Preexisting immunity to AAV vectors can potentially limit their clinical usefulness by blocking tissue transduction and/or by causing the elimination of vector-transduced cells. We previously demonstrated that the AAV2-neutralizin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af05d7d7901d63853549ee2929623944
https://doi.org/10.1016/j.ymthe.2004.06.038
https://doi.org/10.1016/j.ymthe.2004.06.038